←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Vaccines, Shared Neoantigens
Drew Pardoll
MD, PhD
🏢Johns Hopkins University🌐USA
Director, Bloomberg-Kimmel Institute
145
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Drew Pardoll is a leader in cancer vaccine development and has advanced multiple cancer-testis antigen vaccination strategies. He directs the Bloomberg-Kimmel Institute for Cancer Immunotherapy and has shaped understanding of shared tumor antigens as immunotherapy targets.
Share:
🧪Research Fields 研究领域
cancer vaccines
shared neoantigens
cancer-testis antigens
tumor immunology
checkpoint combinations
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Drew Pardoll 的研究动态
Follow Drew Pardoll's research updates
留下邮箱，当我们发布与 Drew Pardoll（Johns Hopkins University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment